Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Neurology
Published in: Journal of Neurology 12/2011

01-12-2011 | Letter to the Editors

Levodopa-induced breathing, cognitive and behavioral changes in Parkinson’s disease

Authors: Nicola Tambasco, Vincenzo Belcastro, Antongiulio Gallina, Anna Castrioto, Paolo Calabresi, Aroldo Rossi

Published in: Journal of Neurology | Issue 12/2011

Login to get access

Excerpt

Dear Sirs, …
Appendix
Available only for authorised users
Literature
1.
Pal PK, Sathyaprabha TN, Tuhina P, Thennarasu K (2007) Pattern of subclinical pulmonary dysfunctions in Parkinson’s disease and the effect of levodopa. Mov Disord 22(3):420–424PubMedCrossRef
2.
Mehanna R, Jankovic J (2010) Respiratory problems in neurologic movement disorders. Parkinsonism Relat Disord 16:628–638PubMedCrossRef
3.
Rice JE, Antic R, Thompson PD (2002) Disordered respiration as a levodopa-induced dyskinesia in Parkinson’s disease. Mov Disord 17(3):524–527PubMedCrossRef
4.
Jankovic J, Nour F (1986) Respiratory dyskinesia in Parkinson’s disease. Neurology 36:303–304PubMed
5.
De Keyser J, Vincken W (1985) L-dopa-induced respiratory disturbance in Parkinson’s disease suppressed by tiapride. Neurology 35(2):235–237PubMed
6.
Weiner WJ, Goetz CG, Nausieda PA, Klawans HL (1978) Respiratory dyskinesias: extrapyramidal dysfunction and dyspnea. Ann Intern Med 88(3):327–331PubMed
7.
Farid K, Sibon I, Guehl D, Cuny E, Burbaud P, Allard M (2009) Brain dopaminergic modulation associated with executive function in Parkinson’s disease. Mov Disord 24(13):1962–1969PubMedCrossRef
8.
Cools R, Barker RA, Sahakian BJ, Robbins TW (2001) Enhanced or impaired cognitive function in Parkinson’s disease as a function of dopaminergic medication and task demands. Cereb Cortex 11:1136–1143PubMedCrossRef
Metadata
Title
Levodopa-induced breathing, cognitive and behavioral changes in Parkinson’s disease
Authors
Nicola Tambasco
Vincenzo Belcastro
Antongiulio Gallina
Anna Castrioto
Paolo Calabresi
Aroldo Rossi
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
Journal of Neurology / Issue 12/2011
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-011-6119-5

Other articles of this Issue 12/2011

Journal of Neurology 12/2011 Go to the issue

Pioneers in Neurology

Mykhailo Mykytovych Lapinsky (1862–1947)

Letter to the Editors

Seizure, syncope, or both: cardiac pacemaker reveals temporal lobe epilepsy

Original Communication

Structural and metabolic damage in brains of patients with SPG11-related spastic paraplegia as detected by quantitative MRI

Letter to the Editors

Adult onset Pompe disease associated with multiple sclerosis

Original Communication

The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases

Letter to the Editors

Vagus nerve somatosensory evoked potentials in Parkinson’s disease